Hematopoietic Stem Cell Transplantation activity levels vary across European countries. No data are available on the homogeneity of access to the transplant procedure for patient with leukaemia, within any European country. We measured homogeneity of the rate of alternative donor search in patients affected by acute leukaemia resident in each Italian region and macro-region during years 2010-2013. A total of 2747 alternative donor searches were studied. Twenty-one percent of all donor searches were made through extra-regional migration. Rate of alternative donor searches varied among the country's regions and macro-regions. The rate of donor searches was 38% lower in South Italy than in North Italy, and the rate of alternative donor transplantations performed was 45% lower. A reduced rate of alternative donor search in South macro-region was observed in all age cohorts. Despite the overall allogeneic transplant rate in Italy is relatively high, there are wide regional differences in access to transplant from alternative donor. Extra-regional migration cannot completely compensate for the lower access to transplant of acute leukaemia patients living in those regions where transplant activity is low.
Introduction
Hematopoietic stem cell transplantation (HSCT) is a lifesaving procedure. However, it requires considerable economic resources and multidisciplinary expertize; for these reasons, access to HSCT suffers a great inequality across various world regions. High variability of the allogeneic transplant rate in different nations has already been reported and found to significantly correlate with economic indexes [1, 2] . Few studies have addressed the degree of regional variability in use of this procedure within a nation [3, 4] . In Spain, transplantation activity varies widely between different regions [3] and similarly, an unequal distribution exists in Japan [4] and in Italy [5] . However, it is not known which are the consequences that regional differences in transplantation activity may have for patients in terms of their access to transplant. In fact, extra-regional migration could compensate for the different levels of activity, ensuring that all patients have equal access in spite of regional differences in transplant activity. In the US, the unmet need for transplantation is not distributed homogeneously [6] and is considered to be high in both adult and pediatric age groups. No data are available on regional disparities in access to HSCT within a single European country and on consequent unmet health needs. According to a review on this topic [7] , further studies are needed on the issue of access to HSCT.
We undertook a study to measure heterogeneity in access to allogeneic alternative donor transplant among patients affected by acute leukaemia who live in different parts of Italy. We restricted our analysis to alternative donor transplant because, at the time of the activation of unrelated donor search, the information about the region in which the patient resides is regularly captured, only for this type of transplant. In addition, we chose to study patients requiring an unrelated donor search because the search procedure is performed at an early stage of alternative donor transplantation and thus may be considered as a formal declaration of "intention to treat." Our analysis used data obtained from donor registries to study disparity in patient access to transplant from alternative donors. We focused our study on patients affected by acute leukaemia because, in this setting, allogeneic transplantation is a quite standardized post-remission therapy [8] , therefore the rate of alternative donor searches was expected to be similar among patients living in different Italian regions. Our analysis, performed nation-wide, allowed us to study in Italy not only regional heterogeneity in access to alternative donor search and transplantation but also to estimate the unmet need in alternative donor transplantation and to quantify the extent of extra-regional migration.
Patients and methods

Donor search registration
In Italy, donor search is performed through the Italian bone marrow donor registry (IBMDR), which acts as the national donor search hub for all patients lacking an HLA compatible sibling. IBMDR registration is required when searching for an unrelated adult donor or for unrelated cord blood as well when the intention of clinician is a haplo-identical transplantation.
Demographic data of patients for whom a search for an alternative hematopoietic stem cell donor was activated during years 2010, 2011, 2012, 2013 , are described in Table 1 . A total of 2747 searches for alternative donor, in four years, were analyzed. During the period considered, the number of searches increased by an average of 3% per year (647 in 2010, 668 in 2011, 706 in 2012 and 726 in 2013). Sixty-five percent of all patients for whom a donor search was activated (1787 patients) received a HSCT. Distribution of donor type in these transplants was as follows: 70.0% from unrelated adult donor, 19.0% from haplo-identical and 11.0% from unrelated cord blood. In Italy during the year 2010 a total of 717 allogeneic HSCT were registered in patients affected by acute leukaemia, of these 36.5% were from matched related donors and 73.5% from alternative donors. Distribution of donor type in these transplants performed from alternative donors was: 61.2% from unrelated adults donors, 23.2% from haplo-identical donors and 15.6% from cord blood.
Study design
This was a retrospective multicentre study, a statistical analysis plan was approved in May 2014 by IBMDR and by the Committee for clinical studies of Italian group for bone marrow transplant and cellular therapy (GITMO). From their institutional database, IBMDR extracted data concerning the disease and demographic information of each patient registered at the activation of an alternative donor search (including unrelated, cord blood and haplo-identical donors) for all Italian patients affected by Acute myeloid leukaemia (AML) and Acute lymphoblastic leukaemia (ALL) from January 2010 to December 2013. Patients included were in all phases of their disease. Data were divided according to the patients' region and macro-regions of residence declared at the time of donor search, as indicated in Table 2 (all ages patients), Table 3 (adult patients) and Table 4 (pediatric patients). Regional population data and statistical analysis
Regional population data and age distribution were obtained from the web site: http://www.tuttitalia.it/statistiche/. Regional economical index (Gross Domestic Product per capita) was obtained from the European statistical atlas: http://ec.europa. eu/eurostat/statistical-atlas/gis/viewer/?year=2015&chapter= 06. Macro-regions were defined as groups of regions having some common features, macro-regions were identified according to Italian Statistic Institute (ISTAT). The need to resort to an alternative donor search is affected by family size [9] . Chance of finding at least 1 matched sibling is equal to 1 minus the chance of not finding any matched sibling, 1-0.75 n (where n is the sibling rate) [9] . Accordingly, chance of finding an HLA compatible donor within a patient's family was considered to be 25% if there was one healthy sibling, 44% in the case of 2 siblings and 58% for 3 siblings. Data on changes in the number of family siblings in various Italian macro-regions in recent years were obtained from a recent University of Padua graduate thesis [10] . An age-specific correction factor and an overall ageweighted correction factor were derived in order to correct differences in family size between the North and South macro-regions. In each age cohort, and for the two macro-regions, the probabilities of finding a donor inside the family (p) or the need to turn to an alternative donor search (1−p) was determined (see attached supplemental data). The ratio between the need for an alternative donor existing in each age cohort in the two macro-regions was the "age-specific correction factor".
Subsequently an absolute number of "ideal unco.rrected search needs" was obtained in each age interval in South macro-region by considering the number of inhabitants in each age-interval in this region and applying the donor search rate actually found in North Italy for the same ageinterval. The absolute number of "ideal uncorrected search needs" in each age interval in South Italy was corrected multiplying it by the "age-specific correction factor" and thus obtaining the "corrected search needs".
To obtain an "overall age-weighted correction factor", the "corrected search needs" of each age interval in South Region were summed and compared to the sum of "ideal uncorrected search needs". The percentage of total "corrected search needs" was 84.5% of the "ideal uncorrected search needs", this percentage was used as the "overall age-weighted correction factor".
Results
Regional and macro-regional donor search data
Rates of donor search in all Italian regions are reported in Table 2 (adults and pediatric patients), Table 3 (adult patients only) and Table 4 (pediatric patients only). Aggregated data for the four Italian macro-regions are reported in Table 5 . The rate of donor search in patients affected by acute leukaemia and living in South Italy was only 62% of the rate in North-West and North-East regions (8.9/million inhabitants/year in South Italy vs. 14.5/million inhabitants/year). Similarly, when the number of transplants from alternative donors actually performed as a result of 
Region
Macroregion these donor searches is analyzed, the rate of alternative donor transplants in acute leukaemia patients in South Italy was 5.8/million inhabitants/year compared to 10.5 in North regions (North-East and North-West regions) ( Table 4) ; alternative donor transplant rate in South was equal to 55% of the rate in the two North-West and North-East regions.
An "ideal activation rate" of 14.5/million inhabitants/year was deduced by excluding extreme search rates registered in Center Italy (17.1/million inhabitants/year) and South Italy (8.9/million inhabitants/year).
To exclude the possibility that a difference in age distribution among populations in the various regions was the cause of the observed variability in search rate, we calculated macro-regional differences in various age cohorts ( Fig. 1) : a lower activation rate in South Italy was present in all age cohorts considered.
Extra-regional migration in donor search
Overall, 21% of all donor search activations (573/2721) were performed in a region other than the one where patients declared they were currently resident and this was considered "extra-regional migration". The mean extra-regional migration for adults patients was 15.7% (range: 2.9-100%). In 8/20 regions extra-regional migration was over 20%.
In the pediatric population (age ≤ 18 years) mean extraregional migration was 37.5% (range: 0-100%). In 12/20 regions extra-regional migration for pediatric patients was over 20%.
A quantification of the extra-regional migration burden as an absolute number is shown in Fig. 2 and its estimated at 149 patients/year.
Quantification of met and unmet donor search needs
An ideal donor search rate of 14.5/million inhabitants/year was obtained by excluding the two macro-regions having extreme results (Center and South Italy). The unmet donor search rate in South Italy was then calculated as 5.6/million inhabitants/year (14.5-8.9 = 5.6). The absolute number of unmet donor searches in South of Italy resulted (5,6 × 18.9 million) to be 106 patients/year. A cautious correction of this number equal to a 15.5% decrease was applied, correction was made using the "overall age-weighted correction factor" (see supplemental data for the calculation of this factor). The corrected number of donor search deficits in Italy was finally estimated to be 90 patients/year. The ideal rate of donor search in South of Italy after applying the "overall age-weighted correction factor", resulted in 12.3/ million inhabitants/year.
The absolute number of regional migration and estimated absolute number of patients lacking a donor search activation as well as their percentage with respect to an estimation of overall needs are reported in Fig. 2 . Overall, a transplant from an alternative donor represents a significant health problem in 1/3 of all Italian acute leukaemia patients.
Correlation of search rate in acute leukaemia patients with economic index As expected [1, 2] , we found a significant correlation between rate of donor searches/million inhabitants/year and regional Gross Domestic Product pro-capita (GDP) (R = 0.629; p = 0.001; Fig. 3 ).
Discussion
In this study, we show that, in patients with acute leukaemia, the access to the initial phase of alternative donor search procedure varies significantly across regions of Italy, although the transplant rate in Italy is equivalent to that reported in most European countries [11] . Furthermore, there is a significant internal migration to obtain access to the transplant.
The wide differences in access to alternative donor transplantation were unexpected. The Italian health system Fig. 2 Health needs for donor search: unmet needs, met by extraregional migration and met within region. Donor search in patients affected by acute leukaemia is not optimal in 30% of patients, either because it is met by extraregional migration or because it remains unmet. *Total health needs = absolute number of donor searches expected in Italy is equal to 802 searches. this calculation is based on number of donor search in all Italy plus unmet needs estimated to occur in south of Italy. **Met health needs is equal to the actual absolute number of donor searches observed in Italy = N 712. ***Unmet Health needs: calculated from the differences in rate observed in South Italy and in north regions and multiplied by population in South Italy (in millions). a correction was applied to take into account family size difference (color figure online) is of the universal type and it is based on the rule that a treatment, if approved and listed in the minimal level of care, has to be available to all citizens free of charge. However, the implementation of universal health coverage requires additional factors such high-quality Institutions and high-quality governance [12] .
Besides the possible regional differences in the quality of health organization and governance, several factors might explain our findings. First, the treatment of acute leukaemia is complex and requires a high degree of coordination to implement efficiently and effectively the various steps of the entire process (induction, post-induction therapy, response and risk stratification assessment, pre-transplant evaluation, donor search, and transplant). Thus, the presence of clinical activities that are poorly coordinated among the different teams involved in leukaemia treatment may negatively affect access to allogeneic transplant, while the development of a national network aimed to coordination of all phases of acute leukaemia treatment, conceivably, will have a beneficial effect.
The impact of different economic resources in the use of allogeneic hematopoietic transplantation is evident from the high correlation found in our data between the regional Gross Domestic Product per capita and the donor search rate. In this respect, our results extend to donor search the already known correlation between rates of transplantation and economic resources [1, 2] .
There is the relative paucity of adequate data to monitor access to HSCT. Although national HSCT activity in Europe is periodically monitored by most national transplantation societies and health authorities and by European Blood and Marrow Transplantation (EBMT), the analysis of data only at national level hides any regional variation. Regional data on transplant activity is seldom analyzed [3, 4] . Furthermore, interpretation of regional data, in terms of the chance to access transplantation for a patient resident in a specific region, is difficult if the rate of patient migration in another region is unknown and, therefore, is not taken into account.
To gain an insight into the chance of a patient to access the donor search, we undertook an alternative approach. We determined how many acute leukaemia patients, residents in each region obtained donor search or transplantation anywhere in Italy. Then the number of such patients was divided by the inhabitants of the same region. This approach accounts for migration among regions and allows for a reliable calculation of the rate of access to alternative donor HSCT.
Our study is the first estimating the inter-regional migration made in order to have access to HSCT. The major finding of this analysis is that migration among regions does not fully offset the reduced transplant capacity of some regions.
We have used data on the donor search rate to measure access to transplantation, which has not previously been done. Such data are readily available in most countries from each national donor registry. The use of donor search data offers some advantages in respect to transplant activity and should complement transplant data. In fact, donor search activity is obtained from a number of patients wider than those transplanted. Another advantage is the fact that donor search is registered 1-2 months before transplantation, thus, donor search rate allows to avoid the potential bias of a different early relapse rates among different centers. A further advantage is that access to donor search is not influenced by differences in the chance of finding a matched donor in international registries while comparison of transplant rates in different regions may be influenced by this chance [13] . The rate of donor search is, however, influenced by the probability of a finding a suitable sibling donor and hence by family size.
Since allogeneic transplantation is considered the best treatment for post remission therapy for high-risk acute leukaemia, a lower rate of transplant use could increase heterogeneity in acute leukaemia treatment and could lead to a poorer treatment outcome in some European regions. A recent European study reported there is variability in the outcome of acute leukaemia treatment among different European regions [14] . Health inequities exist among European countries [15] and it is likely that an uneven rate of access to alternative donor transplant existing in some European nations may be one of the causes of the acute leukaemia outcome variation that has been observed.
In US, a nation not providing universal health coverage, estimation of unmet needs for HSCT from alternative donor, in AML patients, has been calculated to be 41-61% of the needs, depending on patient ages [7, 16] . In this nation, factors important in explaining reduced chance to access transplantations are the type of health insurance, age, race and size of the hospital where the underlying disease is treated [7] . The unmet need estimates in US is higher than the overall unmet needs we calculated in Italy, 11.3%. However, significance of these differences is uncertain since the estimate of unmet need that we made in Italy has been calculated taking as ideal need the search rate actually performed in the regions having a high income. Thus, this calculation may underestimate the real need. In fact, also in highly industrialized countries, alternative donor transplant is underused: only 50% of patients that could be expected to receive it are actually treated [17, 18] . Universal health coverage is not sufficient per se to overcome disparities in access the health care system [19, 20] . The implementation of universal health coverage system can be maximized by organizational and governance quality [12] , but these factors may vary across Europe. It is likely that variation in access to hematopoietic transplant may exist for patients with acute leukaemia in European countries even though many of European nations have a universal health system and an adequate overall transplant rate. Provision for a higher demand for transplant in the near future [21, 22] may have a further negative impact on homogeneity in access to transplant procedure, especially in regions where the health system is less developed or for ethnic minorities.
For all these reasons, a study seems warranted to measure HSCT accessibility among patients resident in different regions of the European continent.
